A more recent study showed that pDCs obtained from the blood of SSc patients have the IRE1α-XBP1 signaling pathway downregulated, which contributes to the type I IFN signature observed in this pathology [119] (Figure 2b). This evidence concerns the gene XBP1 and systemic sclerosis.